Summary
Areas of interest at 3MOrganization name
3M Corp.Profile
3M Drug Delivery Systems provides world-class Inhalation and Transdermal Drug Delivery product development and manufacturing to pharmaceutical and biotech companies. They combine the agility of a leading drug delivery company with the resources of a major, multinational corporation which is supported by 3M's annual R&D budget of over one-billion dollars.
Successfully teaming their delivery technology with molecules from many major pharmaceutical firms has helped make us a world leader in inhalation and transdermal drug delivery. 3M's proven track record includes development of the first metered-dose inhaler (MDI), development of the first seven-day, stand-alone transdermal system. Products manufactured by 3M Drug Delivery Systems are currently sold in more than 60 countries on 6 continents.
3M's in-house resources are available to support each step of the development process from early stages through post-approval. Corporate resources include technology centers and divisions producing component materials. In-house resources include pharmacokinetics, drug metabolism, clinical affairs, toxicology, analytical, regulatory affairs, quality assurance, operations and marketed product support.
3M develops, manufactures, and sells branded prescription drug products related to
- dermatology
- women´s health
- sexual health
- respiratory medicine
- cardiology
3M is developing immune response modifiers (IRMs), which stimulate the human body´s immune system to fight disease.
Whether accessing their system's development capabilities or using their transdermal or inhalation components for your own development program, you'll benefit from their global development, regulatory, and manufacturing expertise. Take a closer look at their developing technologies to meet tomorrow's drug delivery challenges.
Additional information is provided online.
print this page
